• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Business Directory
    • Buyers | Licensees
    • Sellers | Ancillary Businesses
    • Submit Product & Service Press Release
  • CBE Exchange
  • CBE Jobs Exchange
  • Events
  • Featured Videos
  • Product & Service Press Releases
  • Sponsored Polls
  • Webinars
    • Upcoming Webinars
    • Archived Webinars
  • Whitepapers

Cannabis Business Executive - Cannabis and Marijuana industry news

Recreational, Medical, Marijuana, Cannabis, And Hemp News for Cannabis Businesses

  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2
  • Home
  • Policy & Legal
    • Hemp Business Executive
    • International
      • Canada
      • Mexico
      • Israel
    • US A to F
      • Alabama
      • Alaska
      • Arizona
      • Arkansas
      • California
      • Colorado
      • Connecticut
      • Delaware
      • District of Columbia
      • Florida
    • US G to M
      • Georgia
      • Hawaii
      • Illinois
      • Indiana
      • Idaho
      • Iowa
      • Kansas
      • Kentucky
      • Louisiana
      • Maine
      • Maryland
      • Massachusetts
    • US M to N
      • Michigan
      • Minnesota
      • Mississippi
      • Missouri
      • Montana
      • Nebraska
      • Nevada
      • New Hampshire
      • New Jersey
      • New Mexico
      • New York
      • North Carolina
      • North Dakota
    • US O to V
      • Ohio
      • Oklahoma
      • Oregon
      • Pennsylvania
      • Rhode Island
      • South Carolina
      • South Dakota
      • Tennessee
      • Texas
      • Utah
      • Vermont
    • US V to W
      • Virginia
      • Washington
      • Wisconsin
      • Wyoming
      • Guam
      • Puerto Rico
  • Industry News
    • Advertising, Marketing, PR & Research
    • Banking, Finance & Real Estate
    • Compliance and Regulations
    • Corporate Social Responsibility
    • Retailers
    • Hemp Business Executive
    • HR and Staffing
    • North Of The Border
    • Industry People/On the Move
    • Packaging and Supplies
    • Press Releases
    • Processors
    • Producers
    • Security Solutions
    • Science and Technology
    • South Of The Border
  • CBE Lists
    • Ancillary Businesses
      • 2019 CBE Ancillary Business Survey CLICK HERE
      • 2018 CBE 155 A/B
      • 2017 CBE 150 A/B
      • 2016 CBE 100 A/B
    • Producers, Processors, Retailers
      • 2017 CBE 200 PPRs
      • 2015 CBE 100 PPRs
    • Industry Women
      • Glass Ceiling Wreckers: 2019 CBE Power Women of Cannabis
      • 2017 CBE 75 Most Important Women
      • 2016 CBE Top 50 Women
      • 2014 CBE Most Influential Women
    • Most Important Companies
      • 2016 CBE 10 Most Important Companies
      • 2014 CBE 10 Most Important Companies
    • Political 100
      • 2017 CBE Political 100
      • 2016 CBE 100 Political
      • 2014 CBE Political 50
    • 2014 CBE 100 Most Important People
    • CBE RFP Hotlists
      • 2014 CBE Lab Testing Services HotList
      • 2016 BHO Extraction Equipment
      • 2016 CBE Supercritical CO2 Extraction Equipment
      • 2016 CBE Security Solutions
      • 2016 Edibles & Infused Products
  • Company Stories
    • Up and Comers
  • Hemp Business Executive
    • Hemp Policy & Legal
    • Hemp Industry News
    • Hemp State Regulatory Agencies
  • Newsletters
    • CBE Week
    • CBE Human Capital Management
    • CBE Technology & Solutions
    • CBE Policy and Legal Update
    • CBE Product and Service Announcements
  • Op-Ed
    • Cartoons
    • The Buck Stops Here
    • Opinions
    • Comments
  • Associations
  • State Regulatory Agencies
    • Marijuana
    • Hemp
  • Contact
  • AB Survey
  • About Us
  • Account
  • Accounting Services
  • Advertise
  • Advertising, PR & Marketing
  • All Cannabis News
  • Ancillary Business Survey 2018
  • Ancillary Business Survey 2019
  • Archived Webinars
  • Associations & Organizations
  • Banking & Payment Processing
  • Better Start for the Glass Ceiling in this Industry, CBE’s Most Influential Women
  • Book Reviews
  • Business Directory
  • Business Directory Introduction
  • Business Directory Listing
  • Business Directory Manage
  • Business Directory Registration Info
  • Business Directory Welcome
  • Call for speakers
  • Cannabis Investments
  • Cart
  • CBE Exchange
  • CBE HotLists
    • CBE Lab Testing Services HotList 2014
  • CBE Lists
  • CBE Political 50
  • CBE Press LLC Privacy Statement
  • CBE Press News
  • Checkout
  • Consulting Services
  • Consumption Gear
  • Contact
  • Contribute
  • Contributors
  • Create Your Product & Service Press Release
  • Creative Submission
  • Cultivation Products & Services
  • Current Poll
  • Edible & Infused Products
  • Editor’s Page
  • Email Whitelisting Instructions
  • Event Listing Questionaire
  • Featured Videos
  • Funding Options
  • Hemp State Regulatory List
  • Home
  • Human Capital Management Newsletters
  • Industry Jobs
  • Join the CBE Business Directory
  • Join the Directory
  • Lab Testing Regulations
  • Lab Testing Services
  • Login
  • Logout
  • Marijuana State Regulatory Contacts
  • Marijuana Tax Facts
  • Media Kit
  • Medical Marijuana Qualifying Conditions
  • Members
  • MJ Media Kit
  • Most Popular Stories
  • Most Read Stories
  • New Product & Service Listings Welcome
  • News Releases
  • Newsletters
    • Ask CBE
    • CBE Human Capital Management
    • CBE Policy and Legal Update
    • CBE Product and Service Announcements
    • CBE Technology & Solutions
    • CBE Week
  • On the Move
  • Organizations & Associations
  • Packaging & Supplies
  • Password Reset
  • Policy & Legal
  • PPR Survey
  • Product Releases
  • Profile Update
  • Register
  • Security Solutions
  • Software & Technology
  • Sponsored Polls
  • State Cannabis Product Packaging Requirements
  • Terms of Service
  • Thank You
  • The Most Influential People in the Cannabis Industry, The Cannabis Business Executive 100
  • Training & Educational Services
  • Upcoming Webinars
  • User
  • Whitepapers
  • WV Senate passes medical marijuana bill to House
  • Categories
  • Locations
  • My Bookings
You are here: Home / Op-Ed / Opinions / DEA and Big Pharma: The Tangled Web of the Opioid Crisis
DEA Opioid Crisis

DEA and Big Pharma: The Tangled Web of the Opioid Crisis

October 10, 2016 by Ralph Morgan 1 Comment

By Ralph Morgan

Cannabis Industry leaders and activists are seemingly the only two groups with a sense of urgency to find a reasonable alternative pain remedy to replace synthetic opioids. Pharmaceuticals are responsible for a death every 19 minutes. Big Pharma, in order to preserve pride and profit, is funding opposition to deter cannabis legalization in upcoming elections.  That, in concert with the Drug Enforcement Administration’s announcement earlier this year that it will not reschedule marijuana, shows why industry leaders and cannabis activists are leading the fight against opioid addiction.

I believe the successful ballot initiatives in Arizona, California, Maine, Massachusetts, and Nevada this November will help serve as a catalyst and further launch reform efforts of marijuana laws, ultimately accelerating research to find the solution replacing dangerous opioids with cannabis.

Some may ask how an industry can be responsible for the leading cause of accidental death and still exist, even prosper? Money is a major factor. Big Pharma has the largest lobbying budget of any industry in the world, outspending the next highest by one billion dollars.

The Washington Post reported that a “$500,000 donation earlier this year from Insys Therapeutics, based in Chandler, AZ, amounts to more than one-third of all money raised by Arizonans for Responsible Drug Policy, the group opposing legalization. It’s one of the largest, single contributions to any anti-legalization campaign, according to campaign finance records. Insys has had problems in the past that include a class action lawsuit for offering a kickback scheme to increase off-label prescriptions for their drug Subsys, a pain pill for cancer patients and a product threatened by a natural, less addictive substance like cannabis.”

As incredible as the numbers are, they are understated. The same report also states that GW Pharmaceuticals has paid nothing in lobbying fees to date, which is a hard sell for the company currently leading the marijuana monopoly in the U.S.

Medical Marijuana Research

MJBIZ Daily reported the possibility that more medical research into cannabis “did take a step forward” when the University of Pittsburgh’s School of Medicine began advertising that it’s looking for partners to collaborate on cannabis-related studies.

At least three other major institutions have expressed similar interest, even before the DEA’s August announcement that it won’t reschedule cannabis, but will open more doors to medical research. To date, however, the DEA “hasn’t received” any applications for permits to either conduct MMJ research or to grow cannabis for research purposes.

“To my knowledge, we haven’t had anybody apply yet,” said Melvin Patterson of the DEA public affairs office. “I think people will. They’re just making sure they get their protocol together. There’s a lot of prep work that has to go into that.” Yes, prep work and red tape.

As the U.S. government drags its feet on rescheduling cannabis because it is defined as having no medicinal value, it awarded itself a patent to treat specific ailments. Patent number 6630507 is irony at its finest, and a flagrant example of the bureaucracy that is impeding the cannabis industry and the American ideology of the plant.

This fall, people are experiencing fear with the upcoming elections. There are some scary forces trying to mask the truth about the realities and promising medical efficacy of cannabis. Cannabis doesn’t only threaten Pharma, but it threatens the old guard which is entangled in a web of bureaucracy that controls most of America today.

Marijuana is not only the new American industry, but the new American icon. It represents the people; it represents freedom of choice; and it represents one of the most profound civil right movements of this generation. Marijuana looks, smells, and is freedom.  With so few choices to be proud of this November, I’ll be watching closely as America votes for cannabis.

 

 

Ralph Morgan

C.E.O. O.penVAPE

­­­­

 

 

 

 

 

 

 

Filed Under: Opinions, The Buck Stops Here Tagged With: Big Pharma, Drug Enforcement Administration, GW Pharmaceuticals, Insys, Melvin Patterson, O.penVAPE, Ralph Morgan

About Ralph Morgan

As CEO of O.penVAPE, Ralph Morgan sets direction, strategy and media relations for the world’s largest cannabis company.

A visionary entrepreneur, Morgan’s determination to provide access to cannabis as a safer alternative medicine led to the founding of O.penVAPE.
After graduating from the University of Nevada, Reno in 1996, Morgan held several executive and sales positions for health care companies including Smith and Nephew, Stryker Orthopedics and Med1Online.

Foreseeing the many financial and medical benefits of legalized cannabis, Morgan seized the chance to combine his health care experience with his passion to help others and founded O.penVAPE in 2012 alongside four other partners.

Two years prior to O.penVAPE, Morgan founded Organa Labs, the world’s largest and longest running extraction facility. He also opened his first dispensary, Colorado Harvest Company, in the same year with the help of business partner Tim Cullen. Many consider Colorado Harvest Company the most important landmark on Denver’s Green Mile, a one-mile stretch of boulevard with the highest concentration of cannabis shops in the world. Morgan and Cullen own the three Colorado-based dispensaries that, on average, round out each year with approximately 94,000 cash transactions.

In 2015, Ralph accepted the first Trail Blazer Award from High Times Magazine, a publication that has been covering cannabis for 40 years. Today, Morgan is one of the few individuals possessing the depth of knowledge and experience necessary to run a world class organization in the newest American industry. Industry and community leaders, advocacy groups and members of the media seek Morgan’s advice and value his expert insights.

Primary Sidebar

Ad: Sidebar 1

Featured Video

Associations & Organizations

clearing div

Ad: Sidebar 2

Business Directory

Ad: Skyscraper 1

CBE Jobs Exchange


Featured Jobs
Go
Post a Job
More jobs
Powered by CBEJobsExchange.com

RSS Recent Jobs

  • Business Development Officer - Specialty Ag - Bank Michigan - Ann Arbor, MI
  • Field Applications Support Scientist - Danaher - Framingham, MA
  • Flash Chromatography Applications Chemist - VRS Recruitment - , NY

Product & Service Press Releases

Ad: Sidebar 3

CBE Events

Ad: Sidebar 4

State Regulatory Agencies

Ad: Skyscraper 2

Webinars

Ad: Sidebar 5

Associations & Organizations

Ad: Sidebar 6

Featured Video

Ad: Skyscraper 3

Business Directory

Ad: Sidebar 7

CBE Jobs Exchange

Ad: Sidebar 8

CBE Events

Ad: Skyscraper 4

Industry Blogs



Footer

  • Home
  • About Us
  • Advertise
  • Contact
  • CBE Press LLC Privacy Statement
  • Contribute
  • Contributors
  • Newsletters
  • Terms of Service
  • Contributor Login
  • Follow on Facebook
  • Follow on Twitter
  • Follow on Google+
  • Follow on LinkedIn
  • Subscribe to our RSS feed
Newsletter 2

© Copyright 2020 CBE PRESS LLC. - All Rights Reserved. Cannabis Business Executive Is A Trademark Of CBE PRESS LLC. · All Rights Reserved · And Our Sitemap · All Logos & Trademarks Belong To Their Respective Owners·